You are here

Treatments

Depressant fluvoxamine not effective in reducing COVID inflammation--study

 

A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Black cancer patients have much higher rates of COVID hospital stays. according to new study

Race, COVID-19 infections, and chronic disease contributed to higher COVID-related hospitalization rates for Black patients compared to white patients, according to new research from scientists at Louisiana State University (LSU) Health, New Orleans, School of Public Health published in the Journal of the National Cancer Institute.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Treatments
howdy folks